Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Lucid Diagnostics (LUCD) Preferred Dividend Payments (2024 - 2026)

Lucid Diagnostics filings provide 2 years of Preferred Dividend Payments readings, the most recent being $3.4 million for Q2 2025.

  • On a quarterly basis, Preferred Dividend Payments changed N/A to $3.4 million in Q2 2025 year-over-year; TTM through Dec 2025 was $12.6 million, a 67.54% increase, with the full-year FY2025 number at $12.6 million, up 67.54% from a year prior.
  • Preferred Dividend Payments hit $3.4 million in Q2 2025 for Lucid Diagnostics, down from $9.1 million in the prior quarter.
  • In the past five years, Preferred Dividend Payments ranged from a high of $9.1 million in Q1 2025 to a low of $3.4 million in Q2 2025.